LifeStance Health Debt to Equity Ratio 2020-2026 | LFST
Current and historical debt to equity ratio values for LifeStance Health (LFST) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. LifeStance Health debt/equity for the three months ending June 30, 2026 was 0.18.
| LifeStance Health Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-06-30 | $0.70B | $1.48B | 0.48 |
| 2026-03-31 | $0.67B | $1.48B | 0.45 |
| 2025-12-31 | $0.68B | $1.52B | 0.45 |
| 2025-09-30 | $0.66B | $1.49B | 0.44 |
| 2025-06-30 | $0.67B | $1.47B | 0.46 |
| 2025-03-31 | $0.65B | $1.46B | 0.44 |
| 2024-12-31 | $0.67B | $1.45B | 0.47 |
| 2024-09-30 | $0.67B | $1.44B | 0.47 |
| 2024-06-30 | $0.69B | $1.43B | 0.48 |
| 2024-03-31 | $0.68B | $1.43B | 0.47 |
| 2023-12-31 | $0.68B | $1.43B | 0.48 |
| 2023-09-30 | $0.72B | $1.46B | 0.50 |
| 2023-06-30 | $0.68B | $1.50B | 0.45 |
| 2023-03-31 | $0.65B | $1.51B | 0.43 |
| 2022-12-31 | $0.66B | $1.52B | 0.43 |
| 2022-09-30 | $0.45B | $1.53B | 0.29 |
| 2022-06-30 | $0.44B | $1.53B | 0.29 |
| 2022-03-31 | $0.42B | $1.54B | 0.27 |
| 2021-12-31 | $0.38B | $1.55B | 0.25 |
| 2021-09-30 | $0.37B | $1.55B | 0.24 |
| 2021-06-30 | $0.37B | $1.55B | 0.24 |
| 2021-03-31 | $0.65B | $0.95B | 0.68 |
| 2020-12-31 | $0.57B | $1.00B | 0.57 |
| 2020-09-30 | $0.00B | $0.00B | 0.00 |
| 2020-06-30 | $0.00B | $0.00B | 0.00 |
| 2020-03-31 | $0.00B | $0.00B | 0.00 |
| 2019-12-31 | $0.45B | $-0.17B | -2.69 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $4.991B | $1.424B |
| LifeStance Health Group Inc. is provider of virtual and in-person outpatient mental health care for children, adolescents and adults of mental health conditions. LifeStance Health Group Inc. is based in SCOTTSDALE, Ariz. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |